Watch Ticker

DBV Technologies S.A.

Go to DBV Technologies S.A. Website

$9.55

-0.17 (-1.75%)

Live

Previous Close

$9.72

Day Range

$9.55 - $10

Previous Day Range

$9.4 - $9.899

Market Cap

$265.9 million USD

Day Vol.

16937

Previous Day Vol.

30978

Currency

USD

Primary Exchange

Nasdaq

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document

DBV Technologies, a biopharmaceutical company, announced the filing of its 2024 Annual Report and Universal Registration Document, which include audited financial statements and other regulatory filings.

Related tickers: DBVT.

Read Full Article

N/A - DBV Technologies Announces Plan to Implement ADS Ratio Change

DBV Technologies, a biopharmaceutical company, announced plans to change the ratio of its American Depositary Shares (ADSs) to its ordinary shares from 1:1 to 1:5. This change is intended to enable the company to regain compliance with the Nasdaq minimum bid price requirement.

Related tickers: DBVT.

Read Full Article

Trending Tickers

Please sign in to view